Saol Therapeutics
Marion King has six years of experience in the pharmaceutical industry. Marion began their career in 2005 as a Senior Analytical Development Chemist at Ipsen Manufacturing Ireland Ltd. In 2013, they became an Expert Committee Member at U.S. Pharmacopeia. In 2017, they were an Analytical Sciences Manager at Sanofi Genzyme. Most recently, in 2019, they were appointed Senior Manager, Analytical and Formulation Development at Saol Therapeutics.
Marion King completed a PhD in Analytical Chemistry from Dublin City University in 2003, after obtaining a BSc in Analytical Chemistry from Munster Technological University in 1999. Marion then went on to earn a Diploma in First Line Management from National College of Ireland in 2007, before finally obtaining a Master's Degree in Management from University College Dublin in 2016.
This person is not in any teams
This person is not in any offices
Saol Therapeutics
Saol Therapeutics (pronounced “Sail”) is a privately-held, specialty biotech pharmaceutical company with operations in both Roswell, GA and Dublin, Ireland. Saol, focused on neuroscience (spasticity) and rare disease, is committed to providing and advancing therapeutic options for patients and the physicians treating these populations.